+

Toggle voterbase

Statistics are shown for this demographic

Answer Overview

Response rates from 134 Vancouver 87 voters.

90%
Yes
7%
No
81%
Yes
7%
No
4%
Yes, but only for low income families
0%
No, we cannot afford to add this at the moment
3%
Yes, but only when a high cost threshold is exceeded
1%
Yes, cover the overall prescription costs but have the patient pay the pharmacy dispensing costs

Historical Support

Trend of support over time for each answer from 134 Vancouver 87 voters.

Loading data...

Loading chart... 

Historical Importance

Trend of how important this issue is for 134 Vancouver 87 voters.

Loading data...

Loading chart... 

Other Popular Answers

Unique answers from Vancouver 87 voters whose views went beyond the provided options.

 @B4TXJ28 answered…3hrs3H

Yes but putting someone on drugs should be the last option and rather changing the persons lifestyle therefore less people to be on drugs.

 @B4SR555from Alberta  answered…2 days2D

yes, but only for prescriptions that are detrimental; antibiotics for infection etc. Not ozempic for weight loss that is not an urgent matter.

 @B4RNJZYfrom Ontario  answered…4 days4D

All provinces have their own drug program, but Canada should pay for all maintenance cancer drugs under universal healthcare.

 @B4MZCRFfrom Ontario  answered…1wk1W

- yes, but those bringing in an income of ie 120k + should be purchasing their own.
- yes, and government needs to enact laws that require businesses to have benefit coverage, including the part time employees, when companies started working in that loophole to stop having full time workers to avoid paying benefits!!!

 @B4HZF6Dfrom Ontario  answered…2wks2W

Yes if medications are needed to maintain their health and are expensive such as diabetes medications.

 @B46NKYCfrom Saskatchewan  answered…4wks4W

Yes, but doctors are more strict when handing out prescriptions. So drug users aren't getting access to easy prescription drugs

 @B3W9T5Dfrom Ontario  answered…1mo1MO

Yes, and enact a single drug insurer as a price negotiation body and launch a drug value assessment agency